Medicare Rx Regional Map Proposal Expected Week Of Dec. 6
This article was originally published in The Pink Sheet Daily
The proposed regional map for competition among private plans participating in the Medicare prescription drug benefit is expected to be unveiled the week of Dec. 6
You may also be interested in...
The agency has completed inspections of foreign facilities and is considering whether the vaccines manufactured there are appropriate for use as investigational new drugs, HHS says.
FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.
Studies that look for differences in efficacy among members of the same drug class are only performed when necessary for approval, CDER Office of Medical Policy Director Temple tells DIA. While questioning the introduction of "follow-on" compounds, Temple also highlights AstraZeneca's success in achieving a more optimal dose for Nexium.